Spironolactone
Spironolactone, sold under the brand name Aldactone among others, is a medication that is primarily used to treat fluid build-up due to heart failure, liver scarring, or kidney disease. It is also used in the treatment of high blood pressure, low blood potassium that does not improve with supplementation, early puberty in boys, acne and excessive hair growth in women, and as a part of transgender hormone therapy in transgender women. Spironolactone is taken by mouth.
Common side effects include electrolyte abnormalities, particularly high blood potassium, nausea, vomiting, headache, rashes, and a decreased desire for sex. In those with liver or kidney problems, extra care should be taken. Spironolactone has not been well studied in pregnancy and should not be used to treat high blood pressure of pregnancy. It is a steroid that blocks the effects of the hormones aldosterone and testosterone and has some estrogen-like effects. Spironolactone belongs to a class of medications known as potassium-sparing diuretics.
Spironolactone was discovered in 1957, and was introduced in 1959. It is on the World Health Organization's List of Essential Medicines. It is available as a generic medication. In 2018, it was the 63rd most commonly prescribed medication in the United States, with more than 12million prescriptions.
Q12140
medication
Concept
Q152234
fluid build-up
Concept
Q181754
heart failure
Concept
Q147778
liver scarring
Concept
Q1054718
kidney disease
Concept
Q41861
high blood pressure
Concept
Q794086
low blood potassium
Concept
None
supplementation
UNK
Q224513
early puberty
Concept
Q79928
acne
Concept
Q1620594
excessive hair growth
Concept
Q5903807
transgender hormone therapy
Concept
Q1052281
transgender women
Concept
Q285166
by mouth
Concept
Q3269441
side effect
Concept
Q1326943
electrolyte abnormalities
Concept
Q605259
high blood potassium
Concept
Q19001368
high blood pressure of pregnancy
Concept
Q177911
steroid
Concept
Q410943
block
Concept
Q11364
hormone
Concept
Q184564
aldosterone
Concept
Q1318776
testosterone
Concept
Q48841284
estrogen
Concept
Q1123792
potassium-sparing diuretic
Concept
Q37155
World Health Organization's List of Essential Medicines
MEDIA
Q506319
generic medication
Concept
Q422188
Spironolactone
Concept
Q422188
Spironolactone
Concept
Q422188
Spironolactone
Concept
Q422188
Spironolactone
Concept
Q422188
Spironolactone
Concept
1957-01-01T00:00:00Z^^http://www.w3.org/2001/XMLSchema#dateTime
1957
DATE
1959-01-01T00:00:00Z^^http://www.w3.org/2001/XMLSchema#dateTime
1959
DATE
2018-01-01T00:00:00Z^^http://www.w3.org/2001/XMLSchema#dateTime
2018
DATE
+63^^http://www.w3.org/2001/XMLSchema#decimal
63
NUMBER
+12^^http://www.w3.org/2001/XMLSchema#decimal
12
NUMBER
instance of
medical condition treated
medical condition treated
instance of
instance of